BioXcel Therapeutics (BTAI) Other Non Operating Income (2022 - 2026)

BioXcel Therapeutics has reported Other Non Operating Income for 5 years, with the latest figure at -$394000.0 in Q2 2026.

• On a quarterly basis, Other Non Operating Income fell 159.97% year-over-year to -$394000.0 in Q2 2026; TTM through Jun 2026 was -$9.6 million, a 162.68% decrease from a year earlier, with the FY2025 full-year figure at -$3.5 million, down 117.44% from the prior year.
• Other Non Operating Income was -$394000.0 for Q2 2026 at BioXcel Therapeutics, down from $1.5 million in the prior quarter.
• The five-year high for Other Non Operating Income was $12.0 million in Q2 2024, with the low at -$12.5 million in Q3 2025.
• Average Other Non Operating Income over 5 years is $1.1 million, with a median of $322500.0 recorded in 2023.
• The sharpest annual moves came in 2024 and 2025: Other Non Operating Income soared 96440.0% in 2024, then plunged 360.45% in 2025.
• Over 5 years, Other Non Operating Income stood at -$480000.0 in 2022, then jumped by 122.5% to $108000.0 in 2023, then surged by 2953.7% to $3.3 million in 2024, then slumped by 45.06% to $1.8 million in 2025, then slumped by 121.74% to -$394000.0 in 2026.
• The last three Other Non Operating Income figures came in at -$394000.0 (Q2 2026), $1.5 million (Q1 2026), and $1.8 million (Q4 2025), per Business Quant data.